This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Matthew McAskin Has Joined Evercore As Senior Managing Director In Its Healthcare Group

Evercore (NYSE:EVR) announced today that Matthew McAskin has joined the Firm's Investment Banking business as a Senior Managing Director in its Healthcare Group. Mr. McAskin is based in New York and will focus on advising clients in the healthcare services sector.

Mr. McAskin was most recently a Managing Director and co-head of Healthcare Services Investment Banking at Goldman Sachs. With over 17 years of banking experience at Goldman Sachs and JPMorgan, Mr. McAskin has extensive experience advising a broad array of healthcare services companies and private equity firms, and he has advised on a number of the most recent notable transactions in the hospital, managed care, HCIT, physician services and outsourced medical services subsectors.

Roger Altman, Evercore’s Executive Chairman, said, “We are extraordinarily pleased to have a banker of Matthew’s quality and experience join Evercore to help us build-out our capabilities in healthcare services, an active and important sector within the healthcare industry.” Ralph Schlosstein, Evercore’s President and Chief Executive Officer, said, “Healthcare represents one of the largest and most active industries for investment banking services. With Matthew joining our existing senior team of Francois Maisonrouge, John Honts, and Sean Murphy, which has advised on a number of the most important healthcare transactions in recent years, we are able to provide extremely high quality coverage across all key sectors of the healthcare industry.”

“Evercore’s reputation for quality, independence and providing differentiated advice is well known in the marketplace,” said Mr. McAskin. “In addition, Evercore has made a tremendous commitment to building a leading healthcare advisory business, and I look forward to being a part of that effort.”

Mr. McAskin received his BA in Economics from the University of Michigan and received MBA degrees from Columbia Business School and London Business School.

About Evercore

Evercore is a leading independent investment banking advisory firm. Evercore’s Investment Banking business advises its clients on mergers, acquisitions, divestitures, restructurings, financings, public offerings, private placements and other strategic transactions and also provides institutional investors with high quality research, sales and trading execution that is free of the conflicts created by proprietary activities. Evercore’s Investment Management business comprises wealth management, institutional asset management and private equity investing. Evercore serves a diverse set of clients around the world from its offices in New York, Boston, Chicago, Minneapolis, Houston, Los Angeles, San Francisco, Washington D.C., Toronto, London, Aberdeen, Scotland, Mexico City and Monterrey, Mexico, Hong Kong and Rio de Janeiro and São Paulo, Brazil. More information about Evercore can be found on the Company’s website at www.evercore.com.



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,076.97 -3.17 -0.02%
S&P 500 2,112.92 -4.77 -0.23%
NASDAQ 5,063.92 -28.1650 -0.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs